386 results match your criteria: "Sakurabashi Watanabe Hospital.[Affiliation]"
JACC Asia
June 2023
Department of Medicine II, Kansai Medical University, Osaka, Japan.
JACC Cardiovasc Interv
June 2023
Cardiovascular Center, Sakurabashi Watanabe Hospital, Osaka, Japan.
Ann Epidemiol
September 2023
Department of Medical and Health Information Management, National Cerebral and Cardiovascular Center, Suita, Japan.
Purpose: Whether acute cardiovascular diseases (CVDs), such as acute heart failure (AHF), acute myocardial infarction (AMI), and acute aortic dissection (AAD), have distinct seasonal variations in the number of hospitalizations and in-hospital mortality was investigated using a nationwide database in Japan.
Methods: The hospitalized patients with AHF, AMI, and AAD between April 2012 and March 2020 were identified. Multilevel mixed-effects logistic regression was conducted and adjusted odds ratio (aOR) was calculated.
Cardiovasc Interv Ther
October 2023
Cardiovascular Center, Sakurabashi Watanabe Hospital, 2-4-32 Umeda, Kita-Ku, Osaka, 530-0001, Japan.
Eur Heart J Cardiovasc Pharmacother
July 2023
Department of Public Health, Health Management and Policy, Nara Medical University, Kashihara, Nara, Japan.
Aims: Sodium-glucose cotransporter 2 inhibitor (SGLT2i) improves clinical outcomes in patients with heart failure (HF), but has limited evidence of SGLT2i use in early-phase acute coronary syndrome (ACS). We determined association of early SGLT2i use compared with either non-SGLT2i or dipeptidyl peptidase 4 inhibitor (DPP4i) use in hospitalized patients with ACS.
Methods And Results: This retrospective cohort study that used the Japanese nationwide administrative claims database included patients hospitalized with ACS aged ≥20 years between April 2014 and March 2021.
Transfusion
June 2023
Central Blood Institute, Japanese Red Cross, Tokyo, Japan.
Background: Hepatitis B virus (HBV)-positive individuals with isolated anti-HBs are found among HBV vaccine recipients and healthy blood donors with no vaccination history. HBV infectivity from blood transfusions derived from such individuals remains unclear.
Case Presentation: A male patient who received transfusion with blood negative for individual donation-NAT, HBsAg and anti-HBc but weakly positive for anti-HBs developed typical transfusion-transmitted (TT)-HBV with anti-HBc response.
HeartRhythm Case Rep
April 2023
Cardiovascular Center, Sakurabashi Watanabe Hospital, Osaka, Japan.
J Cardiol
September 2023
Department of Cardiology, National Cerebral and Cardiovascular Center, Suita, Japan.
Background: We aimed to determine the usefulness and sex differences of assessment of coronary artery calcification (CAC) with cardiovascular risk factors and major adverse cardiovascular events (MACE) in Japanese patients.
Methods: In a nationwide, multicenter, prospective cohort study, 1187 patients with suspected coronary artery disease who underwent coronary computed tomography were enrolled. MACE included cardiovascular death, myocardial infarction, stroke, revascularization, and hospitalization for unstable angina, heart failure, or aortic disease.
Clin Cardiol
May 2023
Department of Cardiology, National Cerebral and Cardiovascular Center, Suita, Japan.
Background: To examine the utility of fractional flow reserve by coronary computed tomography (CT) angiography (FFR ) for predicting major adverse cardiovascular events (MACE) in patients with suspected coronary artery disease (CAD).
Methods: This was a nationwide multicenter prospective cohort study including consecutive 1187 patients aged 50-74 years with suspected CAD and had available coronary CT angiography (CCTA). In patients with ≥50% coronary artery stenosis (CAS), FFR was further analyzed.
J Interv Card Electrophysiol
October 2023
Division of Cardiology, Saiseikai Kumamoto Hospital Cardiovascular Center, Kumamoto, Japan.
Background: Isolation of the pulmonary veins (PVs) is the golden standard for atrial fibrillation (AF) ablation. To achieve a permanent PV isolation, the endoscopic guided HeartLight laser balloon system was invented. We analyzed the safety and efficacy of this laser balloon system.
View Article and Find Full Text PDFJ Cardiol
June 2023
Department of Cardiovascular and Renal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.
Background: The impact of shorter door-to-balloon (DTB time on long-term outcomes in ST-segment elevation myocardial infarction (STEMI treated with primary percutaneous coronary intervention (PPCI has not been fully elucidated.
Methods: We investigated 3283 consecutive patients with acute myocardial infarction selected from a prospective, nationwide, multicenter registry (J-MINUET database comprising 28 institutions in Japan between July 2012 and March 2014. Among the study population, we analyzed 1639 STEMI patients who had PPCI within 12 h of onset.
Cardiovasc Interv Ther
April 2023
Department of Cardiology, Tokai University School of Medicine, Isehara, Japan.
The Task Force on Rotational Atherectomy of the Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT) proposed the expert consensus document to summarize the techniques and evidences regarding rotational atherectomy (RA) in 2020. Because the revascularization strategy to severely calcified lesions is the hottest topic in contemporary percutaneous coronary intervention (PCI), many evidences related to RA have been published since 2020. Latest advancements have been incorporated in this updated expert consensus document.
View Article and Find Full Text PDFAm J Cardiol
March 2023
Cardiovascular Center, Sakurabashi Watanabe Hospital, Osaka, Japan; Cardiovascular Division, National Hospital Organization Osaka National Hospital, Osaka, Japan. Electronic address:
Functional mitral regurgitation (FMR) negatively impacts the prognosis in patients with atrial fibrillation (AF) and reduced left ventricular (LV) ejection fraction (LVEF). Although structural reverse remodeling after AF ablation can reduce FMR severity, the prognostic impact of FMR and its evolution remain unclear. Of 491 patients with baseline LVEF <50% who underwent first-time AF ablation, 134 patients (27%) had grade 2 to 4 FMR at baseline.
View Article and Find Full Text PDFHeartRhythm Case Rep
November 2022
Cardiovascular Center, Sakurabashi Watanabe Hospital, Osaka, Japan.
Am J Cardiol
February 2023
Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Surg Case Rep
December 2022
Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Background: Intrapulmonary penetration of the thoracic aorta is a rare, life-threatening complication of a chronic dissecting aortic aneurysm. It causes massive hemoptysis requiring prompt intervention to prevent fatal airway bleeding. A surgical approach that enables diverse surgical maneuvers and intraoperative organ protection is crucial.
View Article and Find Full Text PDFCirc J
January 2023
Boston Scientific Corporation.
Background: Drug-coated balloons (DCB) have shown promising results for the treatment of in-stent restenosis (ISR) and small vessel disease (SVD). However, data comparing the treatment efficacy of different DCBs are limited.
Methods and results: AGENT Japan is a prospective randomized controlled trial that compares the Agent balloon coated with a low-dose formulation of paclitaxel (2 μg/mm) to the SeQuent Please paclitaxel-coated balloon (3 μg/mm) for the treatment of SVD.
Heart Lung Circ
February 2023
Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Can J Cardiol
January 2023
Cardiovascular Center, Sakurabashi Watanabe Hospital, Osaka, Japan.
JACC Case Rep
August 2022
Department of Cardiology, JCHO Hoshigaoka Medical Center, Hirakatashi, Osaka, Japan.
We present the case of a 75-year-old man who experienced rebleeding after surgical treatment of grade III coronary perforation, resulting in intertwined complications including communicating coronary and ventricular pseudoaneurysms. The percutaneous intervention of sealing the rebleeding site with a covered stent implantation managed this rare pseudoaneurysm successfully. ().
View Article and Find Full Text PDFJA Clin Rep
August 2022
Anesthesiology Service, Sakurabashi-Watanabe Hospital, Osaka, Japan.
HeartRhythm Case Rep
August 2022
Cardiovascular Center, Sakurabashi Watanabe Hospital, Osaka, Japan.
J Cardiol
January 2023
Department of Cardiovascular and Renal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.
Background: Beta-blockers are associated with several clinical benefits in patients with reduced left ventricular ejection fraction (REF) after acute myocardial infarction (AMI), such as lower rates of mortality, recurrence of myocardial infarction, and heart failure. However, the long-term prognosis of beta-blockers has rarely been investigated in patients with non-REF after AMI. This study aimed to investigate the clinical benefits of beta-blockers in these patients.
View Article and Find Full Text PDFJA Clin Rep
August 2022
Yoka Municipal Hospital, 1878-1, Yoka, Yoka-cho, Yabu, Hyougo, 667-8555, Japan.
Background: The effect of delirium on cardiopulmonary exercise testing (CPX) is unknown. This retrospective study was to examine the effect of delirium on CPX at discharge in aged patients undergoing cardiac surgery.
Methods: This study included seventy patients aged 70 or older undergoing cardiac valve surgery, who entered our ICU and were discharged from our hospital between June 2016 and July 2018.